Viewing Study NCT00403260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-16 @ 10:59 PM
Study NCT ID: NCT00403260
Status: COMPLETED
Last Update Posted: 2021-11-02
First Post: 2006-11-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients
Sponsor: Medicines for Malaria Venture
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SP-C-004-06
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View